JP Morgan Chase & Co’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $39.2M | Buy |
|
|||||
|
2025
Q2 | $16.5M | Buy |
|
|||||
|
2025
Q1 | $13M | Sell |
|
|||||
|
2024
Q4 | $13.1M | Sell |
|
|||||
|
2024
Q3 | $21.5M | Sell |
|
|||||
|
2024
Q2 | $19.7M | Sell |
|
|||||
|
2024
Q1 | $22.8M | Sell |
|
|||||
|
2023
Q4 | $8.76M | Sell |
|
|||||
|
2023
Q3 | $6.19M | Buy |
|
|||||
|
2023
Q2 | $6.1M | Sell |
|
|||||
|
2023
Q1 | $8.49M | Buy |
|
|||||
|
2022
Q4 | $2.77M | Buy |
|
|||||
|
2022
Q3 | $1.81M | Sell |
|
|||||
|
2022
Q2 | $1.84M | Buy |
|
|||||
|
2022
Q1 | $1.87M | Sell |
|
|||||
|
2021
Q4 | $2.65M | Buy |
|
|||||
|
2021
Q3 | $668K | Buy |
|
|||||
|
2021
Q2 | $427K | Buy |
|
|||||
|
2021
Q1 | $330K | Buy |
|
|||||
|
2020
Q4 | $192K | Buy |
|
|||||
|
2020
Q3 | $180K | Buy |
|